Therefore, we assessed the levels of mTOR (a core component of the mTORC1 complex) and phosphorylated S6K (pS6K) in both ATF3-oe and ATF3-kd HCC cell lines via Western blot analysis. The gene discussed is MTOR; the disease is hepatocellular carcinoma.